TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

13% of US phones made in India

Photo for representational purpose only. File photo

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

The US remained India’s largest trading partner for the fourth consecutive year in 2024-25 with bilateral trade valued at $ 131.84 billion, said the data released on Wednesday by Commerce Ministry.

Advertisement

Notably, among rising exports Indian-made phones now hold 13.74% and 14.31% share in the mobile phone market of the US and UK, respectively. In 2024, India exported smart phones worth $ 7.03 billion to the US, up from $4.7 billion in 2023.

Advertisement

To the UK, India-made smart phones exports during 2024 stood at $1.5 billion, up from the $1.039 billion in 2023.

Commerce Secretray Sunil Barthwal, at a media briefing on Tuesday said exports of smart phone is an area being watched.

The data has emerged as there are ongoing talks of bilateral trade agreement between India and the US. Both are negotiating a trade agreement.

Advertisement

The aim is to increase two-way commerce in goods and services to $ 500 billion by 2030.

Trade representatives will resume virtual talks this week and are scheduled to physical meeting in the second-half of May. Trump first threatened to impose reciprocal tariff on India and then, on April 3 , paused the move for 90 days.

India’s main exports to the US included drug formulations and biologicals — valued at $ 8.1 billion.

Advertisement
Show comments
Advertisement